Modulated Imaging Enters Growth Phase with New Name
Summary
With the company entering the next stage of its growth, they are moving to a larger headquarters (2400 Barranca in Irvine, CA) and are actively expanding the sales, marketing, engineering, and clinical applications teams. “While paying homage to the effort we’ve already invested in our groundbreaking technology, the Modulim name is much more than a simple contraction of ‘Modulated Imaging,’” said David Cuccia, PhD, Modulim’s founding CEO and CTO. The technology is able to provide clinicians with an early warning system for complications due to compromised circulation, including diabetic foot ulcers. The proprietary technology helps clinicians identify compromised circulation and perfusion by measuring microvascular tissue oxygenation and hemoglobin concentration and distribution. With widespread adoption, this approach could save thousands of limbs and lives, as well as billions of dollars in treatment costs.